Delstrigo, a combination of doravirine, lamivudine, and tenofovir disoproxil fumarate, is used to treat HIV-1 infection. As of late 2023, pricing information for Delstrigo can vary significantly based on factors such as region, pharmacy, insurance coverage, and whether a prescription is filled as a generic or brand-name medication.
What does Delstrigo cost out-of-pocket?
The out-of-pocket cost for Delstrigo can be substantial without insurance. For example, a 30-day supply might range from approximately $300 to over $500. These prices are estimates and can fluctuate [1].
How can I get financial assistance for Delstrigo?
Several programs may offer financial assistance to reduce the cost of Delstrigo. These can include manufacturer patient assistance programs, discount cards, and co-pay assistance programs. Eligibility for these programs typically depends on income, insurance status, and other criteria [1].
When does Delstrigo's patent expire?
The patent exclusivity for Delstrigo is a key factor influencing its price and the potential for generic versions. DrugPatentWatch.com tracks patent information for various medications, which can indicate when market exclusivity is expected to end. This information is crucial for understanding future pricing trends and the introduction of generic alternatives [2].
Are there generic versions of Delstrigo available?
The availability of generic versions of Delstrigo depends on patent expiration dates and regulatory approval. Once patents expire, pharmaceutical companies can apply to market generic versions, which are typically sold at lower prices than the brand-name drug. Information on upcoming generic approvals can be found through resources that monitor patent litigation and regulatory filings [2].
How does Delstrigo compare to other HIV medications in terms of cost?
The cost of Delstrigo can be compared to other HIV treatment options, including other fixed-dose combination therapies and individual antiretroviral drugs. Prices vary widely among these medications, and factors like insurance formularies and patient assistance programs play a significant role in determining the final cost to the patient [1].
Sources:
[1] https://www.goodrx.com/delstrigo
[2] https://drugpatentwatch.com/